PPARA and cancer: In a study involving KK mice 3T3-L1 adipocytes, PPARα activation by bezafibrate and GW7647, specific PPARα agonists, resulted in enhanced fatty acid oxidation and changes in gene expression related to both adipogenesis and fatty acid oxidation, highlighting its role in energy metabolism and potential application in cancer therapies (Goto et al., 2011).